These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 26782531)
1. Correlation of increased MALAT1 expression with pathological features and prognosis in cancer patients: a meta-analysis. Shi XS; Li J; Yang RH; Zhao GR; Zhou HP; Zeng WX; Zhou M Genet Mol Res; 2015 Dec; 14(4):18808-19. PubMed ID: 26782531 [TBL] [Abstract][Full Text] [Related]
2. A genetic variant in long non-coding RNA MALAT1 associated with survival outcome among patients with advanced lung adenocarcinoma: a survival cohort analysis. Wang JZ; Xiang JJ; Wu LG; Bai YS; Chen ZW; Yin XQ; Wang Q; Guo WH; Peng Y; Guo H; Xu P BMC Cancer; 2017 Mar; 17(1):167. PubMed ID: 28253859 [TBL] [Abstract][Full Text] [Related]
3. The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasis. Xia H; Chen Q; Chen Y; Ge X; Leng W; Tang Q; Ren M; Chen L; Yuan D; Zhang Y; Liu M; Gong Q; Bi F Oncotarget; 2016 Aug; 7(35):56209-56218. PubMed ID: 27486823 [TBL] [Abstract][Full Text] [Related]
4. Clinical prognostic value of metastasis-associated lung adenocarcinoma transcript 1 in various human cancers: an updated meta-analysis. Li Y; Yang Z; Wan X; Zhou J; Zhang Y; Ma H; Bai Y Int J Biol Markers; 2016 May; 31(2):e173-82. PubMed ID: 26847605 [TBL] [Abstract][Full Text] [Related]
5. High Expression of Long Noncoding RNA MALAT1 Indicates a Poor Prognosis and Promotes Clinical Progression and Metastasis in Bladder Cancer. Li C; Cui Y; Liu LF; Ren WB; Li QQ; Zhou X; Li YL; Li Y; Bai XY; Zu XB Clin Genitourin Cancer; 2017 Oct; 15(5):570-576. PubMed ID: 28648755 [TBL] [Abstract][Full Text] [Related]
6. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis. Liu X; Huang G; Zhang J; Zhang L; Liang Z PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949 [TBL] [Abstract][Full Text] [Related]
7. Circulating long non-coding RNA AFAP1-AS1 is a potential diagnostic biomarker for non-small cell lung cancer. Li W; Li N; Kang X; Shi K Clin Chim Acta; 2017 Dec; 475():152-156. PubMed ID: 29080690 [TBL] [Abstract][Full Text] [Related]
8. Identification of relevant prognostic values of cytokeratin 20 and cytokeratin 7 expressions in lung cancer. Luo HT; Liang CX; Luo RC; Gu WG Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28827446 [TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression. Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer. Pang EJ; Yang R; Fu XB; Liu YF Tumour Biol; 2015 Apr; 36(4):2403-7. PubMed ID: 25481511 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of long noncoding RNA MALAT1 in various carcinomas: evidence from nine studies. Xue Y; Teng YQ; Zhou JD; Rui YJ Tumour Biol; 2016 Jan; 37(1):1211-5. PubMed ID: 26282005 [TBL] [Abstract][Full Text] [Related]
12. High expression of long non-coding RNA MALAT1 in breast cancer is associated with poor relapse-free survival. Wang Z; Katsaros D; Biglia N; Shen Y; Fu Y; Loo LWM; Jia W; Obata Y; Yu H Breast Cancer Res Treat; 2018 Sep; 171(2):261-271. PubMed ID: 29845475 [TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of long non-coding RNA ZXF1 promoted the invasion and metastasis in lung adenocarcinoma. Zhang L; Zhou XF; Pan GF; Zhao JP Biomed Pharmacother; 2014 May; 68(4):401-7. PubMed ID: 24721325 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of long non-coding RNA MALAT1 in cancer patients. Wu Y; Lu W; Xu J; Shi Y; Zhang H; Xia D Tumour Biol; 2016 Jan; 37(1):897-903. PubMed ID: 26254614 [TBL] [Abstract][Full Text] [Related]
15. MALAT1 might be a predictive marker of poor prognosis in patients who underwent radical resection of middle thoracic esophageal squamous cell carcinoma. Cao X; Zhao R; Chen Q; Zhao Y; Zhang B; Zhang Y; Yu J; Han G; Cao W; Li J; Chen X Cancer Biomark; 2015; 15(6):717-23. PubMed ID: 26406400 [TBL] [Abstract][Full Text] [Related]
16. Expression and correlation of MALAT1 and SOX9 in non-small cell lung cancer. Chen W; Zhao W; Chen S; Zhang L; Guo Z; Wang L; Wang J; Wan Z; Hong Y; Yu L Clin Respir J; 2018 Jul; 12(7):2284-2291. PubMed ID: 29896925 [TBL] [Abstract][Full Text] [Related]
17. The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma. Wu Y; Liu H; Shi X; Yao Y; Yang W; Song Y Oncotarget; 2015 Apr; 6(11):9160-72. PubMed ID: 25863539 [TBL] [Abstract][Full Text] [Related]
18. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma. Zhang HM; Yang FQ; Chen SJ; Che J; Zheng JH Tumour Biol; 2015 Apr; 36(4):2947-55. PubMed ID: 25480417 [TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis. Yang SL; Ren QG; Wen L; Hu JL J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):321-327. PubMed ID: 27376798 [TBL] [Abstract][Full Text] [Related]
20. Upregulation of long noncoding RNA MALAT1 in papillary thyroid cancer and its diagnostic value. Liu J; Dong H; Yang Y; Qian Y; Liu J; Li Z; Guan H; Chen Z; Li C; Zhang K; Zhang Q; Cao W; Lv J Future Oncol; 2018 Dec; 14(29):3015-3022. PubMed ID: 29987950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]